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TECHNOLOGY ADVANCES
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Objective: Relevant animal models to study effects of bacterial aggregates on
wound healing are lacking. We aimed at establishing an equine wound model
with bacterial aggregates to investigate the impact of bacterial inoculation on
normal (thorax) and impaired (limb) wound healing.
Approach: Wounds were created on three limbs and both thorax sides of six
horses. Twelve out of 20 wounds per horse were inoculated with 104 Sta-
phylococcus aureus and 105 Pseudomonas aeruginosa on day 4. Healing was
monitored until day 27 by clinical assessment, including wound scoring,
surface pH measurements, and digital photography for area determination.
Biopsies were used for bacterial culture and for peptide nucleic acid fluo-
rescence in situ hybridization to detect bacterial aggregates.
Results: Inoculated limb wounds healed slower than noninoculated limb
wounds from day 10 onward ( p < 0.0001). Inoculated and noninoculated
thorax wounds healed equally well and faster than limb wounds. The odds
ratio of detecting bacterial aggregates in inoculated limb wounds was 7.1
(2.4–21.0, p = 0.0086) compared with noninoculated limb wounds and 36.2
(3.8–348, p = 0.0018) compared with thorax wounds.
Innovation: This equine wound model with bacterial aggregates might be
superior to other animal wound models, as both normal and impaired
healing can be studied simultaneously. In this model, many aspects of
wound healing, including novel treatments, may be studied.
Conclusions: The impaired healing observed in inoculated limb wounds
may be related to the persistent bacterial aggregates. Both in capability of
clearing inoculated bacteria from the wounds and in healing pattern, thorax
wounds were superior to limb wounds.
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INTRODUCTION
Bacterial aggregates, also referred to as bio-
films, are a well-known major contributor to im-
paired wound healing.1–3 Wound healing is a
highly complex process that is difficult to study in
controlled human studies due to the heterogeneity
of wounds and patients. To gain knowledge, many
animal models have been used to investigate the
relationship between bacterial aggregates and
wound healing.4 Most studies use small rodents to
model wound healing. However, skin anatomy and
healing patterns in these species are markedly
different from those found in humans.4 Similar to
humans, horses have tight and thick skin.5,6 Con-
trary to the situation in loose-skinned animals
such as rodents, contraction of wound edges play a
small role (20–25%) in extremity/limb healing in
humans and horses.7,8 Due to the similarities in
skin anatomy and relative importance of contrac-
tion and epithelialization in healing, horses seem
to be valid model animals for wound healing in
humans.9,10 Horses are prone to impaired wound
healing and chronic wound formation, in particular
when wounds are located on the limbs.8,11
Recent research detected bacterial aggregates in
equine chronic wounds and suggested that aggre-
gates might be implicated in the chronic healing
pattern frequently found in equine limbwounds,12–
15 similar to what has been shown in humans.2,3
The pathophysiology underlying delayed healing
in horses and humans share further similarities:
impaired healing of equine limb wounds has been
linked to hypoxia16 and chronic low-grade inflam-
mation,17,18 conditions which are also present in
many types of chronic wounds in humans, for ex-
ample, venous stasis ulcers, diabetic foot ulcers,
and pressure wounds.19,20
This study aimed at inoculating experimental
excisional wounds in horses with Staphylococcus
aureus and Pseudomonas aeruginosa to establish a
model for studying effects of bacterial aggregate
formation in equine limb and thorax wounds.
S. aureus and P. aeruginosa were chosen to mimic
common wound infections in humans,21–23 these
bacteria are incidentally also common wound
pathogens in horses.12,13,24
CLINICAL PROBLEM ADDRESSED
Impaired wound healing is common and causes
high health expenditures and decreased quality of
life of the affected patients. Bacterial aggregates
cause delayed wound healing and are present in
most chronic wounds.3 Improved animal models
are needed to study bacterial aggregates in wounds
to better understand pathogenesis and to test fu-
ture treatment options.
MATERIALS AND METHODS
Horses and clinical examinations
Six mature, mixed breed geldings, 3–10 years
old, weighing 430–500kg, and standing at 149–
63 cm were included in this study. Horses were
found to be healthy on thorough clinical, lameness,
hematological, and biochemical examinations.
None of the horses had scar tissue or other der-
matological diseases near any of the body loca-
tions where wounds were to be created. Before the
initiation of the study, horses underwent de-
worming (Equimax Vet, Virbac Danmark A/S,
Kolding, Denmark), vaccination against tetanus
(ProteqFlu-Te, Boehringer Ingelheim, Copenha-
gen, Denmark), teeth floating, and hoof trimming
as needed. Horses were housed in box stalls and
had either access to a pen or were hand-walked
(2 · 20min) daily; they were fed ad libitum grass
hay and concentrates according to their needs. On
a daily basis, the horses underwent brief clinical
examinations, pain scoring according to ‘‘The
Equine Pain Scale,’’25 and lameness examinations
(using the American Association of Equine Practi-
tioners’ [AAEP] scale26). Furthermore, blood sam-
ples were drawn on day 2, 4, 7, 14, 21, and 27 for
hematological and biochemical analyses. The ex-
perimental protocols were approved by the Large
Animal Teaching Hospital Ethics Committee and
by the Danish Animal Experiments Inspectorate
(license no. 2016-15-0201-00981), and procedures
were performed according to the Danish Animal
Testing Act and EU Directive 2010/63/EU for ani-
mal experiments.
Wound creation
On day 0, horses had wounds created on the
dorsolateral aspect of both metatarsi and one ran-
domly chosen metacarpus and on both sides of the
ventral thorax, just caudal to the shoulder, over the
thoracic serratus ventralis muscle. Horses were
sedated with intravenous detomidine hydrochlo-
ride 1mg/100kg (Domosedan, Orion, Niva˚, Den-
mark), acepromazine 4mg/100kg (Plegicil, Dechra
Veterinary Products A/S, Uldum, Denmark), atro-
pine sulfate 0.5mg/100kg (Skanderborg Apotek,
Skanderborg, Denmark) and buthorphanoltartrate
2mg/100kg (Torbugesic, Orion, Niva˚, Denmark)
and the sedations were maintained with xylazine
hydrochloride continuous infusion (Xylavet, Scan-
Vet Animal Health A/S, Fredensborg, Denmark)
titrated to effect. The body locations to be wounded
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were anesthetizedwith regional nerve blocks using
a 1:1:1 mixture of 1.9% lidocaine hydrochloride
(Lignovet, ScanVet Animal Health A/S, Fre-
densborg, Denmark), 0.5% bupivacaine (Marcaine,
AstraZeneca, Albertslund, Denmark), and isotonic
saline. Before creation of wounds, hair was clipped
and skin aseptically prepared using 2 ·4min scrub
with 4% chlorhexidine gluconate (Medi-Scrub,
Rovers Medical Devices B. V., Oss, Netherlands)
followed by multiple applications of 70% isopropyl
alcohol. Four excisional wounds were created
(2 ·2 cm, 2 cm apart) in a vertical column on each of
the five body locations using a scalpel and a flexible
sterile template made from x-ray film. Wounds
were full thickness and did not include the perios-
teum at the metatarsi/-carpi or the subcutaneous
muscle fascia at the thorax. Wounds were photo-
graphed within 5min of creation to measure the
initial areas. All wounds were left to heal by sec-
ond intention and were bandaged using sterile
nonadhesive gauze (Melolin, Smith & Nephew,
Hørsholm, Denmark). For the limb wounds, the
dressing was secured using cotton and elastic ad-
hesive wrap (KRUUSE Vet-Flex and KRUUSE
Vet-Plast; Jørgen Kruuse A/S, Langeskov, Den-
mark), while on the thorax, the dressing was held
in place by absorbent dressing pads (Zetuvit;
HARTMANN-ScandiCare AB, Anderstorp, Swe-
den) and elastic adhesive wrap (KRUUSEVet-Flex
and KRUUSE Vet-Plast, Jørgen Kruuse A/S, Lan-
geskov, Denmark). On day 0 (before surgery) and 1,
horses received flunixin meglumine 1.1mg/kg
(Flunixin; ScanVet Animal Health A/S, Fre-
densborg, Denmark) to minimize discomfort asso-
ciated with the surgical procedure. Furthermore,
for the first 14 days of the study, the horses re-
ceived omeprazole (Gastrogard,Merial NordenA/S,
Copenhagen, Denmark) to reduce risk of gastric
ulcer development.
Wound inoculation
All four wounds on two randomly chosen limbs
and one randomly chosen thorax side were inocu-
lated with *104 colony-forming units (CFU) S. au-
reus (clinical isolate from an equine wound) and
*105 CFU P. aeruginosa (PAO1 wild type)27 on day
4. Bacterial strains and concentrations were di-
rected froma previous pilot study as described below.
Bacterial suspensions were prepared by inocu-
lating freeze cultures on blood agar plates (SSI
Diagnostica, Hillerød, Denmark) for 18h at 37C.
One colony of each strain was grown in Luria–
Bertani (LB) broth (Panum Institute Substrate
Department, University of Copenhagen, Denmark)
over night at 37C by 180 rpm. Overnight cultures
were reinoculated into LB broth and grown at 32C
by 180 rpm for further 22h.
Bacterial suspensions were washed, resusp-
ended in isotonic saline, adjusted to OD600nm (op-
tical density at 600nm) 0.3 (*108 CFU/mL) and
OD600nm 0.4 (*5·107 CFU/mL) for P. aeruginosa
and S. aureus, respectively, and diluted to final sus-
pensions. The inoculation suspensions were subse-
quently plated and the bacterial concentrations were
verified.
The suspensions were kept on ice and trans-
ported directly to the equine facility to inocu-
late the wounds. On day 4, 0.5mL suspension of
S. aureus (containing*104 CFU) and 0.5mL sus-
pension of P. aeruginosa (containing *105 CFU)
were added simultaneously on 2 ·2 cm nonadhe-
sive gauze that were applied to the wounds to be
inoculated (12 per horse). The remaining eight
wounds were treated with 1mL isotonic saline
applied to 2 ·2 cm nonadhesive gauze. After ap-
plication of bacterial suspensions or isotonic saline,
wounds were bandaged as described above.
Pilot study to establish inoculation
dose and timing
To establish inoculation doses and timing of ap-
plication of bacteria, a pilot study was performed
before the main study described above. This in-
cluded one horse (5 years old warm blood gelding,
161 cm, and 480kg). The wounding procedure for
the horse was as described above, and inoculation
was performed earlier, 2 days after surgery. Three
different S. aureus strains (two clinical wound
isolates and one laboratory strain) and one P. aer-
uginosa (PAO1 wild-type) were prepared as de-
scribed above and applied in dosages of*106 CFU
and*107 CFU per wound either alone or together.
Eighteen out of 20 wounds were inoculated. The
day after inoculation, the horse developed fever
(40.1C, normal below 38.5C), and 2 days after
inoculation, the horse showed sign of septicemia
with fever, elevated heart rate, and severely ele-
vated levels of inflammatory markers in blood.
Eight days after, inoculation levels of inflamma-
tory markers had increased to serum amyloid
A (SAA) =5032mg/L (normal 0–30mg/L) and white
blood cell count =24 ·109/L (normal 5.45–12.65·
109/L). Despite aggressive treatment with anti-
inflammatory medication (flunixin meglumine
1.1mg/kg two times daily), signs of septicemia
progressed and the horse was therefore euthanized
8 days after inoculation. BacteremiawithS. aureus
was confirmed by culture on blood obtained 5 and
6 days after inoculation. Due to the course of the
pilot study, inoculation dosages were reduced
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markedly and inoculation postponed to 4 days after
wound creation.
Clinical wound examinations
and pH measurements
Wounds at each body location were examined on
day 7, 10, 14, 17, 21, and 27 and scored according to
amount of exudate (0/none, 1/mild, 2/moderate, and
3/severe), type of exudate (0/serous-hemorrhagic,
1/mucous, and 2/purulent), epithelialization
(0/present and 1/not present/not visible), level of
granulation tissue (0/below or in level with skin
and 1/above skin level), quality of granulation
tissue (0/even and 1/uneven), and color of granu-
lation tissue (0/pink, 1/red, or dark red). Scores
were totaled to create an overall wound score per
body location per time point (range from 0 to 9).
Surface pH was measured on day 7, 14, 21, and
27 in wounds to be biopsied using a glass surface
electrode (Blueline 27 pH, SI Analytics, Mainz,
Germany)28 and a pH meter (PHM210 Standard
pH Meter, Radiometer Analytical S.A., Villeur-
banne Cedex, France), whichwere calibrated daily.
Circumference and thermometry
Circumference of each wounded limb was mea-
sured between the two middle wounds using a
sterile measuring tape on day 0, 4, 7, 10, 14, 17, 21,
and 27. On the same days, skin temperature was
recorded by thermometry after bandage removal
using a handheld Raynger MX4 infrared ther-
mometer (Raytek GmbH, Berlin, Germany) for 10 s
at a 20 cm distance perpendicular to the skin. The
temperature of the wounded skin on each wounded
limb and thorax side was measured.
Biopsy procedures
Biopsies (6–8mm) from one randomly chosen
wound at each location were collected at day 7, 14,
21, and 27. Before the biopsy procedure, wounds
were gently cleansed with sterile gauze pads soaked
in isotonic sterile saline. All wounds were only
biopsied at one time point, and wounds were ex-
cluded from further analyses once they had been
biopsied. The horses underwent sedation and nerve
blocks as described above and had two biopsies col-
lected: one biopsy (8mm) from the wound margin
(including granulation tissue and migrating epithe-
lia/skin margin) and one biopsy from the center of
the wound (6mm). The margin biopsy was immedi-
ately fixed in 4% formaldehyde, transferred to 70%
ethanol after 1 week, and finally embedded in par-
affin. Biopsies from the wound center of inoculated
wounds at day 7, 21, and 27 were used for bacterio-
logical culture and were stored in sterile cryo tubes
at 5C for up to 40h until further processing.
Wound area measurements
At day 0, 4, 7, 10, 14, 17, 21, and 27 digital pho-
tographyof allwoundswasperformed.Photographs
were obtained using a Panasonic LumixDMC-T220
camera with a 24-mm aspherical lens and 16· op-
tical zoom. In all photographs a flexible sterile ruler
was included for calibration and for identification of
location.Thephotographswereused forwoundarea
measurements by using the image analysis soft-
ware Fiji.29 Wounds that had been biopsied earlier
were not included. Wound perimeter was traced
three times andwoundarea recorded as themean of
these three tracings. The area of the granulation
tissue, not including the advancing edge of epithe-
lium if present, was measured.
Bacterial culture
Wound biopsies were homogenized, sonicated,
diluted in 10-fold series, and plated as 100lL of the
undiluted tissue suspension spread on a plate and
10lL of the dilution-series 100–104 in spots on se-
lective Pseudomonas Isolation Agar plates (Panum
Institute Substrate Department, University of Co-
penhagen, Denmark) and LB plates added 6.5%
NaCl (Panum Institute Substrate Department,
University of Copenhagen, Denmark) selective for
Staphylococci. Theplateswere grownaerobically for
18h at 37C. The CFU counts were calculated from
the number of colonies in the countable dilutions.
Bacterial aggregate detection by peptide
nucleic acid fluorescence in situ hybridization
and confocal laser scanning microscopy
To detect bacterial aggregates, peptide nucleic
acid (PNA) fluorescence in situhybridization (FISH)
was performed as previously described after stan-
dard deparaffinization.14,30 Four replicates/sections
of each margin biopsy were prepared with two dif-
ferent PNA probes; a specific P. aeruginosa Texas
red/universal bacterial (BacUni) FITC (fluorescein
isothiocyanate)-conjugated probe and a specific S.
aureusTamra/BacUni FITC-conjugated probe (both
from AdvanDx, Inc., Woburn, MA). Furthermore, a
nuclear counterstain was performed with 4¢,6¢-
diamidino-2-phenylindole (DAPI).
Microscopic examinations were performed by
confocal laser scanning microscopy (CLSM) (Axio
Imager.Z2, LSM710 CLSM and LSM880 CLSM,
Zeiss, Oberkochen, Germany) and the accompa-
nying 3D reconstruction software (Zen 2010, ver-
sion 6.0, Zeiss, Oberkochen, Germany) as described
previously.14
Bacterial aggregates of >5 lm in diameter have
been categorized as biofilms.31 To grade bacterial
aggregates, a previously used14 categorical semi-
quantification was applied (grade 0, 1, 2 and 3).
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Tissue sections were systematically examined and
bacterial aggregates were semiquantified accord-
ing to the largest aggregate present targeted by
either of the probes.
Statistical analyses
All statistical analyses were performed in SAS
Enterprise Guide 7.1 (SAS Institute, Inc., Cary,
NC). Graphs were made in GraphPad Prism 5
(GraphPad Software, La Jolla, CA). When rele-
vant, data are reported as mean–SD or as pa-
rameter estimates with 95% confidence intervals.
Wound areas, pH values, culture results, wound
scores, circumference, and thermometry measure-
ments were analyzed using two-way ANOVA (fac-
tors being time and wound type [body position and
inoculation status]) with repeated measurements
taking account of correlations between all mea-
surements on the same horse, closer correlation
between wounds at the same position in the same
horse, and furthermore an autoregressive error
structure over time for each wound. For each out-
come variable, limb wounds and thorax wounds
were compared as well as inoculated versus non-
inoculated limb and thorax wounds, respectively.
Blood parameters were analyzed using one-way
ANOVA with autoregressive error structure over
time. Standard model checks were applied for each
analysis before processing. Even though wound
scores were ordinal of nature, they were modeled as
quantitative variables to obtain interpretable con-
clusions. Model checks showed satisfactory nor-
mality and variance homogeneity of residuals. Some
parameters (wound areas, SA, and culture results)
were log-transformed to achieve satisfactory model
checks. For SAA and CFU/biopsy, it was necessary
to give zero values aminimal value of 0.1mg/L and 1
CFU, respectively, to be able to log-transform data.
Detection of bacterial aggregates (yes/no, corre-
sponding to bacterial aggregate grade above 0/equal
to 0) was analyzed using generalized estimating
equations, to allow for correlations between findings
on the same horse. For the thorax wounds, it was
not possible to run a logistic regression model be-
cause of too few data points. Fisher’s exact test was
used to compare grading of bacterial aggregates per
day for each body location, including thoraxwounds.
Level of significance was set at p<0.05.
RESULTS
Clinical observations, hematological,
and biochemical evaluations
All surgical procedures were successful. One
horse was slightly depressed and had slightly in-
creased rectal temperature (38.7C) on day 1. One
horse became ill with strangles (airway infection
with Streptococcus equi ssp. equi, confirmed on
nasal swab culture) on day 4–10 and was isolated
and treated with flunixinmeglumine 1.1mg/kg one
to two times daily.
Four horses developed intermittent (1–3 days
duration) mild lameness (1/5 or 2/5 AAEP grades)
on one wounded limb. One horse developed 4/5
grade lameness on one hind limb on day 23 due to
reaction to the injection of local analgesics; this was
treated once with flunixin meglumine (1.1mg/kg),
and the lameness resolved the day after.
Pain scores remained low throughout the study;
they ranged from 0 to 8 (maximum possible score is
30; a score of 9 or above indicates that additional
pain medication should be provided) in the first
7 days after surgery and from 0 to 4 for the re-
mainder of the study.
Concentrations of inflammatory markers in
blood increased transiently after the surgical pro-
cedure, but did not change in response to the
inoculation procedure (Supplementary Fig. S1).
Blood results from the horse that developed
strangles have been excluded in these analyses.
Wound score, pH, circumference, and skin
temperature
Granulation tissue appeared in all wounds on
day 7. For limb wounds, the granulation tissue
protruded above skin level from day 10 (in one
horse), day 14 (in three horses), or day 17 (in two
horses) onward. None of the thorax wounds devel-
oped exuberant granulation tissue at any time
(Supplementary Fig. S2). Wound scores ranged for
limb wounds between 0 and 8 (median =4) and for
thorax wounds between 0 and 5 (median =1).
Wound scores of limb versus thorax wounds devel-
oped significantly differently over time (p=0.0002),
with wound scores of thorax wounds being consis-
tently lower than wound scores of limb wounds
(Fig. 1). Wound scores were not significantly af-
fected by inoculation (limbwounds: p=0.067; thorax
wounds: p=0.48).
Surface pH measurements (Fig. 2) developed
differently over time in thorax and limb wounds
(p <0.0001), with thorax wounds having signifi-
cantly lower pH than limb wounds on day 21 (pH
difference equal to 0.18, 0.004–0.35, p=0.045) and
day 27 (pH difference equal to 0.45, 0.26–0.64,
p< 0.0001). Inoculation did not affect pH over time
(p =0.75).
Circumferences were similar in limbs with in-
oculated wounds and limbs with noninoculated
wounds throughout the study period (p= 0.36).
Temperatures of the wounded skin were not sig-
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nificantly higher for inoculated versus non-
inoculated wounds (p =0.16).
Area measurements
Thorax wounds showed great immediate retrac-
tion and were 5.80–1.22cm2 shortly after creation;
while limb wounds showed no retraction (area was
3.74–0.52 cm2 shortly after wounds were created).
Size of thorax wounds declined significantly faster
than that of limb wounds (p<0.0001, Fig. 3). In
thorax wounds, inoculation did not affect size
(p=0.71), while in limb wounds size of inoculated
and noninoculated wounds differed significantly
over time (p<0.0001), with inoculated wounds be-
ing larger than the noninoculated wounds from day
10 onward (Table 1).
Bacterial culture
CFU counts of S. aureus per biopsy (Fig. 4A)
developed significantly (p =0.047) differently in
thorax and limbwounds over time. For both wound
locations, S. aureus CFU increased from day 7 to
day 21, but on day 27 CFU in thorax wounds de-
creased, while CFU in limbwounds increased. This
resulted in 31 times (1.6–628, p=0.026) higher
CFU of the limb wounds on day 27 compared with
thorax wounds. CFU counts of P. aeruginosa per
biopsy (Fig. 4B) were generally low and were not
detectable for all wounds on day 21 and 27; P.
aeruginosa CFU counts did not differ significantly
between thorax and limb wounds over time
(p =0.93).
Bacterial aggregate detection
Bacterial aggregates were detected in most in-
oculated limb wounds on day 7 (91%), 14 (100%),
and 21 (100%), and in fewer wounds (40%) on day
27 (Table 2 and Fig. 5). Bacterial aggregates were
detected in some noninoculated limb wounds on
day 7 (80%), 14 (50%), 21 (67%), and 27 (33%). In-
oculated limbwounds had significantly higher odds
Figure 1. Wound score averages of experimental excisional limb and thorax wounds inoculated and not inoculated with Staphylococcus aureus and
Pseudomonas aeruginosa on day 4. Asterisks indicate statistically significant differences between scores of limb and thorax wounds, ***p < 0.001 and
*p< 0.05. There were no significant differences between inoculated and noninoculated wounds of the thorax or of the limbs, respectively. Six horses
participated in the study, each with five wound areas (two limbs with inoculated wounds, one limb with noninoculated wounds, one thorax side with inoculated
wounds and one thorax side with noninoculated wounds); each time point (day) thus includes six observations (one for each horse) per wound type except
inoculated limb wounds, where each time point includes 12 observations (two for each horse; the exception being day 27, where only one inoculated limb
wound was included per horse). Data are reported as mean– SEM.
Figure 2. pH measurements of experimental excisional limb and thorax
wounds inoculated and not inoculated with S. aureus and P. aeruginosa on
day 4. Asterisks indicate statistically significant differences between pH of
limb and thorax wounds, ***p < 0.001 and *p< 0.05. There were no signifi-
cant differences in pH between inoculated and noninoculated wounds of
the thorax or of the limbs, respectively. Six horses participated in the study,
each with five wound areas (two limbs with inoculated wounds, one limb
with noninoculated wounds, one thorax side with inoculated wounds, and
one thorax side with noninoculated wounds); each time point (day) thus
includes six observations (one for each horse) per wound type except
inoculated limb wounds, where each time point includes 12 observations
(two for each horse; the exception being day 27, where only one inoculated
limb wound was included). Data are reported as mean– SD
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of having bacterial aggregates present than the
noninoculated limb wounds (odds ratio 7.1, 2.4–
21.0, p= 0.0086). Furthermore, inoculated limb
wounds had significantly higher bacterial aggre-
gate grades on day 14 (p =0.031) and day 21
(p =0.0087) compared with noninoculated limb
wounds (Table 2). In thorax wounds, bacterial ag-
gregates were found in inoculated wounds only,
and only on day 7 (83%), 14 (50%), and 21 (20%)
(Table 3).
When comparing inoculated thorax and limb
wounds, limbwounds had significantly higher odds
of containing bacterial aggregates than thorax
wounds (odds ratio 36.2, 3.8–348, p= 0.0018).
Aggregates consisted mainly of S. aureus, al-
though a majority of the inoculated thorax wounds
on day 7 contained P. aeruginosa (Tables 2 and 3).
Multispecies aggregates were not detected, but
within the same wound monospecies aggregates of
two bacterial species were seen in several wounds.
Most bacterial aggregates were detected below or
at the wound surface close to the wound margin.
DISCUSSION
Establishment of an equine inoculated wound
model with bacterial aggregates was successful,
and inoculation affected healing of limb wounds
negatively, but had no effect on thorax wounds.
The differences in healing patterns of limb and
thorax wounds observed in this study have been
described in previous studies in horses (without
inoculation), and it is generally accepted that limb
wounds in horses are prone to impaired healing
and chronic wounds.8,14 This difference in propen-
sity for development of chronic wounds depending
on body location is a further benefit of using the
horse as model animal, as it allows researchers to
study impact of bacterial inoculation on wounds
with normal and wounds with poor healing within
the same animal.
Wound healing of equine limb wounds is, simi-
larly to wound healing in humans, mainly depen-
dent on epithelializationwith contraction playing a
minor role.7,8 This makes equine limb wounds
more similar to wounds in humans than rodent
wounds, as healing in rodents occurs mainly by
contraction.4,32 We created full thickness wounds,
as these resemble the dermal losses seen in most
human chronic wounds.33 Another advantage of
our model is that neither mechanical contraptions
of the skin nor medical or genetic modifications of
the animals are needed to inhibit healing, as the
healing in the limbs is naturally impaired. Such
interventions are often necessary to induce im-
paired healing in commonly used rodent wound
models.4,32 Yet, another advantage of using the
horse as model animal is its size, which makes it
possible to create several identical wounds on each
body location. This means that the wounds can
Figure 3. Wound areas (model predicted means and SEMs, log scale) of
equine experimental excisional limb and thorax wounds inoculated and not
inoculated with S. aureus and P. aeruginosa on day 4. Asterisks indicate
statistically significant differences in the areas of inoculated and non-
inoculated limb wounds, ***p< 0.001, **p< 0.01, and *p< 0.05. For thorax
wounds, no differences were detected between inoculated and non-
inoculated wounds throughout the study. Thorax wounds and limb wound
were significantly different in size at all time points (not indicated in the
figure). Six horses participated in the study, each with five wound areas of
four wounds (two limbs with inoculated wounds, one limb with non-
inoculated wounds, one thorax side with inoculated wounds and one thorax
side with noninoculated wounds). At each time point, every wound that had
not previously been biopsied were included (day 4+ 7= 20 wounds per
horse, day 10 + 14 = 15 wounds per horse, day 17 + 21 = 10 wounds per
horse, and day 27 = 4 wounds per horse).
Table 1. Percentage area difference of inoculated (with S. aureus and P. aeruginosa on day 4) relative to noninoculated
limb wounds in an equine experimental excisional wound model
Day 7 Day 10 Day 14 Day 17 Day 21 Day 27
Area difference of inoculated versus
noninoculated limb wounds
(95% confidence interval)
-10.0%
(-22.0% to 0.8%)
31.2%
(13.8–51.1%)
20.7%
(2.6–42.0%)
5.2%
(-12.8% to 27.1%)
32.1%
(7.8–61.9%)
32.2%
(-3.2% to 80.5%)
p-value p= 0.070 p= 0.0002 p= 0.023 p= 0.59 p= 0.0075 p = 0.079
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be considered the biological replicate, not the
animals,34 thereby reducing the number of exper-
imental animals in accordance with the Replace-
ment, Reduction, and Refinement of animal
experimentation. Furthermore, the many wounds
mean that wounds can be followed over time and
samples collected serially without euthanizing the
animals. The welfare aspects of the equine exci-
sional wound model (without inoculation) were
recently assessed,35 and the model was found to
cause mild discomfort and pain manifestations.
Even with bacterial inoculation of several wounds
in the present study, the horses showed only few
and mild episodes of lameness and changes in gen-
eral behavior and showed neither hematological
nor biochemical responses in relation to inoculation.
Therefore, we find the described model acceptable
from an ethical and welfare point of view.
Several factors may explain why bacterial ag-
gregates were more prevalent in inoculated limb
wounds than in inoculated thorax wounds. One
reason could be the less efficient local inflamma-
tory response in limb wounds compared with body
wounds of horses.17,18 In addition, body wounds
have better blood supply and oxygenation,16,36
which are prerequisites for delivery of cells and
factors to the wound bed needed for infection con-
trol and healing and for their function.37 This may
explain why thorax wounds cleared the infection
quite readily and healed with no complications.
Yet, another explanation could be the decreasing
pH of thorax wounds from day 21 and onward, as
lower pH is known to be associated with enhanced
immune response, better antimicrobial defense,
and improved healing.38 Therapeutically lowering
of pH has been shown to increase healing of human
chronic wounds.38
Even in the noninoculated wounds, which were
also maintained under sterile dressings, bacterial
aggregates were still present in 80% of limb
wounds on day 7, thereafter number of aggregates
diminished, which is in line with previous findings
in equine experimental excisional wounds.14 Ap-
parently, bacterial aggregates naturally estab-
lished in the noninoculated limb wounds were
easier for the immune response to eradicate than
aggregates formed in the inoculated wounds, sug-
gesting that inoculation dosage, species, and viru-
lence are important factors during establishment
of wound infections.
Figure 4. CFU counts of (A) S. aureus and (B) P. aeruginosa in biopsies
from equine experimental excisional limb and thorax wounds inoculated with
S. aureus and P. aeruginosa on day 4. Asterisk indicates statistically sig-
nificant differences in CFU counts between limb and thorax wounds,
*p< 0.05. Six horses participated in the study, each with two limbs and one
thorax side with inoculated wounds; each time point (day) thus includes six
observations (one for each horse) per thorax wound and 12 observations
(two for each horse) per limb wound (the exception being day 27, where only
one inoculated limb wound was included per horse). Horizontal lines show
medians. CFU, colony-forming units.
Table 2. Grading of bacterial aggregates and distribution of bacterial species detected in equine experimental excisional limb wounds
inoculated or not inoculated with S. aureus and P. aeruginosa on day 4
Grade/Inoculation
Status
Day 7 Day 14 Day 21 Day 27
Inoculated Noninoculated Inoculated Noninoculated Inoculated Noninoculated Inoculated Noninoculated
0 1 1 0 3 0 2 3 4
1 4 2 2 1 3 3 1 0
2 3 1 5 2 7 0 1 2
3 3 1 5 0 0 0 0 0
Missing 1 1 0 0 2 1 1 0
Bacterial species SA 70%;
PA 50%;
Other 20%
SA 74%;
PA 0%;
Other 50%
SA 83%;
PA 25%;
Other 8%
SA 67%;
PA 0%;
Other 33%
SA 90%;
PA 10%;
Other 20%
SA 100%;
PA 0%;
Other 0%
SA 100%;
PA 0%;
Other 0%
SA 50%;
PA 0%;
Other 50%
Fisher’s exact test
on grade per day
p= 1.0 p= 0.031 p= 0.0087 p= 1.0
PA, Pseudomonas aeruginosa; SA, Staphylococcus aureus.
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Most aggregates were found just below the
wound surface, which resemble the situation in
most chronic wounds.23 This might also partly ex-
plain why resection of granulation tissue often is
curative of wound infection and poor wound heal-
ing in equine limbwounds,24 and the same strategy
is often used in chronic wounds in humans.3 The
effect of resecting granulation tissue was not in-
vestigated in the present study, but this could be
interesting in future studies to investigate causal-
ity between bacterial aggregates and the impaired
healing pattern. Despite the markedly different
healing patterns of thorax and limb wounds, the
CFU counts of S. aureus were not statistically dif-
ferent between these two body locations on day 7
and 21; however, aggregates were found in all limb
wounds but only in one thorax wound on day 21.
This indicates that the immune response toward
the bacteria and whether the bacteria form aggre-
gatesmight bemore relevant than the CFU counts.
On day 27, the inoculated limb wounds had 31
times higher CFUs than the inoculated thorax
wounds, indicating a better capability of the thorax
wounds to clear the bioburden.
Effect of bacterial aggregates on healing oc-
curred in limb wounds from day 10 onward, where
inoculated wounds were larger than noninoculated
ones. Bacterial aggregates affect healing negatively
by eliciting ineffective and poorly coordinated in-
flammatory responses as well as causing collateral
damage to the wound tissue.39,40 The delay between
inoculation and affected wound healing could be
related to the fact that bacterial aggregates need
time to mature and develop, before they will nega-
tively affect the healing.41,42
Even though inoculation affected healing in limb
wounds negatively this was not reflected in the
wound scores. This could be related to individual
Figure 5. Confocal laser scanning microscopy images of bacterial aggregates in inoculated limb wounds in an equine experimental excisional wound model
inoculated with S. aureus and P. aeruginosa on day 4. Top of image is toward surface of wound. Bacterial peptide nuclei acid probes are used to identify,
respectively, S. aureus (A) and P. aeruginosa (B) as red bacterial cells. Equine immune cells appear blue due to DAPI nuclear counterstain. (A) Inoculated
limb wound on day 7 (3 days after inoculation). Large aggregates (grade 3) of P. aeruginosa are seen below the wound surface. (B) Inoculated limb wound on
day 27 (23 days after inoculation). Large aggregates (grade 3) of S. aureus are seen below the wound surface. Scale bar, 10 lm. DAPI, 4¢,6¢-diamidino-2-
phenylindole
Table 3. Grading of bacterial aggregates and distribution of bacterial species detected in equine experimental excisional thorax
wounds inoculated or not inoculated with S. aureus and P. aeruginosa on day 4
Day 7 Day 14 Day 21 Day 27
Grade/Inoculation
Status Inoculated Noninoculated Inoculated Noninoculated Inoculated Noninoculated Inoculated Noninoculated
0 1 6 3 6 4 6 6 6
1 4 0 1 0 1 0 0 0
2 1 0 2 0 0 0 0 0
3 0 0 0 0 0 0 0 0
Missing 0 0 0 0 1 0 0 0
Bacterial species SA 20%;
PA 80%;
Other 20%
SA 0%;
PA 0%;
Other 0%
SA 67%;
PA 33%;
Other 0%
SA 0%;
PA 0%;
Other 0%
SA 100%;
PA 0%;
Other 0%
SA 0%;
PA 0%;
Other 0%
SA 0%;
PA 0%;
Other 0%
SA 0%;
PA 0%;
Other 0%
Fisher’s exact test
on grade per day
p= 0.015 p= 0.18 p= 0.45 p= 1.0
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variation between horses or to the fact that clinical
assessment of whether a wound is infected with
bacterial aggregates or not is extremely difficult. A
recent consensus guideline stated that aggregates
should always be suspected in chronic wounds,
even though specific clinical symptoms rarely
testify to their presence.3 While we did not find
increased periwound skin temperature near inoc-
ulated wounds, one study did report increased
periwound temperatures in human chronic leg ul-
cers with confirmed infection.43
Detection of bacterial aggregates by use of PNA
FISH and CLSM may be flawed, as aggregates are
not evenly distributed in wounds3,23,44 and might
be missed in the thin tissue sections. However, vi-
sual detection by either CLSM or scanning electron
microscopy remains the gold standard of bacterial
aggregate detection,45,46 and to increase the sen-
sitivity, we investigated eight sections of 4 lm from
each wound. Also, when performing bacteriological
culture from wounds, there are risks of not de-
tecting and underreporting bacterial numbers. We
used center biopsies from the wounds for culture in
this study, as biopsies are recommended for culture
of bacteria from chronic wounds in humans, as
swabs might fail to detect bacteria from deeper
layers in the wounds.47,48 However, the heteroge-
neously distribution of bacteria within wounds is
also a ubiquitous risk when sampling biopsies for
culture.31,49
P. aeruginosa CFU counts were low in inocu-
lated limb and thorax wounds; explanations for
this could be that they were eradicated either by
the host responses or the S. aureus, or that the
inoculation procedure was unsuccessful. P. aeru-
ginosamay also have escaped detection; a study of
bacterial aggregate infected wounds in mice
showed that the majority of bacterial aggregates
were found in wound scabs,50 not in granulation
tissue. Also, the cleansing procedure, however
gentle it was, performed before sampling may have
removed bacteria trapped in the often quite tena-
cious exudate overlying the wounds. In humans,
P. aeruginosa is seldom found in acute and devel-
oping wounds, but is often preceded by other bac-
teria, such as Staphylococci, thatmight ‘‘prime’’ the
wound bed before P. aeruginosa then settles as
aggregates in chronic wounds.2 In this regard, our
equinewoundmodel resembles the clinical situation
well, asP. aeruginosadid not settle in thewounds. A
further development of the equine wound model
could be to experiment with a staged inoculation
procedure, postponing the P. aeruginosa inocula-
tion until the limb wounds have a more chronic
appearance after for example, 2–3 weeks.
Inoculation of wounds was done with planktonic-
cultured bacteria to control bacterial numbers4;
this is in contrast to othermodels, where preformed
in vitro bacterial aggregates have been directly
applied to wounds.50 It is unknown whether clini-
cal wounds are infected with planktonic bacteria or
aggregates and it might as well be a mixture of
these types; however, the wound bed plays an es-
sential role in bacterial aggregation and the change
of the bacterial phenotype into the biofilm mode of
growth.3
In conclusion, we succeeded in establishing
an equine experimental excisional wound model
with bacterial aggregates. Mainly S. aureus ag-
gregates were detected, and the aggregates had a
negative influence on the healing pattern of limb
wounds, but not on that of thorax wounds. The
model can be used to investigate many aspects of
the influence of bacterial aggregates on wound
healing, including mechanistic and pathophysio-
logical events. Furthermore, the model can be
used to test future novel treatments against bac-
terial aggregates.
INNOVATION
Bacterial aggregates are a major cause of im-
paired wound healing and development of new
relevant animal models is necessary to investigate
effect of bacterial aggregates on wound healing.
Our equine wound model with bacterial aggregate
formation is in some aspects superior to other an-
imal models, as both normal and impaired healing
patterns toward inoculation and bacterial aggre-
gates can be studied within the same animal over
time. The established model of aggregate-infected
wounds in horses gives us further possibilities to
study the interactions between the immune re-
sponse and the bacteria.
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KEY FINDINGS
 In the established equine model, bacterial inoculation affected wound
healing in limb wounds negatively, but had no effect on thorax wounds.
 Bacterial aggregates were significantly more often present in inoculated
limb wounds than in noninoculated limb wounds and thorax wounds.
 Bacterial inoculation did not affect wound scores and could not be
detected by clinical assessment of the wounds.
 This equine experimental excisional bacterial aggregate-infected wound
model allows both normal and impaired wound healing to be studied
over time.
REFERENCES
1. James GA, Swogger E, Wolcott R, et al. Biofilms
in chronic wounds. Wound Repair Regen 2008;16:
37–44.
2. Bjarnsholt T, Kirketerp-Møller K, Jensen PØ, et al.
Why chronic wounds will not heal: a novel hy-
pothesis. Wound Repair Reg 2008;16:2–10.
3. Schultz G, Bjarnsholt T, James GA, et al. Con-
sensus guidelines for the identification and
treatment of biofilms in chronic nonhealing
wounds. Wound Repair Regen 2017;25:744–757.
4. Seth AK, Geringer MR, Hong SJ, Leung KP, Mustoe
TA, Galiano RD. In vivo modeling of biofilm-infected
wounds: a review. J Surg Res 2012;178:330–338.
5. Jorgensen E, Lazzarini G, Pirone A, Jacobsen S,
Miragliotta V. Normal microscopic anatomy of
equine body and limb skin: a morphological and
immunohistochemical study. Ann Anat 2018;218:
205–212.
6. Davidson JM. Animal models for wound repair.
Arch Dermatol Res 1998;290:S1–S11.
7. Sardari K, Kazemi H, Emami M, Movasaghi A, Goli
A. Role of collagen cross-linking on equine wound
contraction and healing. Comp Clin Pathol 2009;
18:239–247.
8. Wilmink JM, Stolk PWT, Van Weeren PR, Bar-
neveld A. Differences in second-intention wound
healing between horses and ponies: macroscopic
aspects. Equine Vet J 1999;31:53–60.
9. Gordillo GM, Bernatchez SF, Diegelmann R, et al.
Preclinical Models of Wound Healing: is Man the
Model? Proceedings of the Wound Healing So-
ciety Symposium. Adv Wound Care 2013;2:1–4.
10. Theoret CL, Wilmink JM. Aberrant wound healing
in the horse: naturally occurring conditions remi-
niscent of those observed in man. Wound Repair
Regen 2013;21:365–371.
11. Theoret C. Physiology of wound healing. In: The-
oret C, Schumacher J, eds. Equine Wound Man-
agement. Iowa, USA: John Wiley & Sons, Inc.;
2017:1–13.
12. Freeman K, Woods E, Welsby S, Percival SL, Co-
chrane CA. Biofilm evidence and the microbial
diversity of horse wounds. Can J Microbiol 2009;
55:197–202.
13. Westgate SJ, Percival SL, Knottenbelt DC, Clegg
PD, Cochrane CA. Microbiology of equine wounds
and evidence of bacterial biofilms. Vet Microbiol
2011;150:152–159.
14. Jorgensen E, Bay L, Bjarnsholt T, Bundgaard L,
Sorensen MA, Jacobsen S. The occurrence of
biofilm in an equine experimental wound model of
healing by secondary intention. Vet Microbiol
2017;204:90–95.
15. Van Hecke LL, Hermans K, Haspeslagh M, et al. A
quantitative swab is a good non-invasive alter-
native to a quantitative biopsy for quantifying
bacterial load in wounds healing by second in-
tention in horses. Vet J 2017;225:63–68.
16. Sørensen MA, Pedersen LJ, Bundgaard L, Toft N,
Jacobsen S. Regional disturbances in metabolism
and blood flow in equine limb wounds healing
with formation of exuberant granulation tissue.
Wound Repair Regen 2014;22:647–653.
17. Bundgaard L, Bendixen E, Sorensen MA, et al. A
selected reaction monitoring-based analysis of
acute phase proteins in interstitial fluids from
experimental equine wounds healing by second-
AN EQUINE BIOFILM-INFECTED WOUND MODEL 497
ary intention. Wound Repair Regen 2016;24:525–
532.
18. Wilmink JM, Van Weeren PR, Stolk PWT, Van Mil
FN, Barneveld A. Differences in second-intention
wound healing between horses and ponies: his-
tological aspects. Equine Vet J 1999;31:61–67.
19. Mustoe TA, O’Shaughnessy K, Kloeters O. Chronic
wound pathogenesis and current treatment
strategies: a unifying hypothesis. Plast Reconstr
Surg 2006;117:35S–41S.
20. Nouvong A, Ambrus AM, Zhang ER, Hultman L,
Coller HA. Reactive oxygen species and bacterial
biofilms in diabetic wound healing. Physiol
Genomics 2016;48:889–896.
21. Kirketerp-Moller K, Jensen PO, Fazli M, et al.
Distribution, organization, and ecology of bacteria
in chronic wounds. J Clin Microbiol 2008;46:
2717–2722.
22. Wolcott RD, Hanson JD, Rees EJ, et al. Analysis
of the chronic wound microbiota of 2,963 patients
by 16S rDNA pyrosequencing. Wound Repair Re-
gen 2016;24:163–174.
23. Fazli M, Bjarnsholt T, Kirketerp-Moller K, et al.
Nonrandom distribution of Pseudomonas aerugi-
nosa and Staphylococcus aureus in chronic
wounds. J Clin Microbiol 2009;47:4084–4089.
24. Hanson RR. Complications of Equine Wound
Management and Dermatologic Surgery Vet Clin
North Am Equine Pract 2008;24:663–696.
25. Gleerup KB, Lindegaard C. Recognition and
quantification of pain in horses: a tutorial review.
Equine Vet Educ 2016;28:47–57.
26. American Association of Equine Practitioners. La-
meness Exams: Evaluating the Lame Horse. www
.aaep.org/horsehealth/lameness-exams-evaluating-
lame-horse (last accessed November 12, 2018).
27. van Gennip M, Christensen LD, Alhede M, et al.
Interactions between polymorphonuclear leuko-
cytes and Pseudomonas aeruginosa biofilms on
silicone implants in vivo. Infect Immun 2012;80:
2601–2607.
28. Gethin GT, Cowman S, Conroy RM. The impact of
Manuka honey dressings on the surface pH of
chronic wounds. Int Wound J 2008;5:185–194.
29. Schindelin J, Arganda-Carreras I, Frise E, et al.
Fiji: an open-source platform for biological-image
analysis. Nat Methods 2012;9:676–682.
30. Fazli M, Bjarnsholt T, Hoiby N, Givskov M, Tolker-
Nielsen T. PNA-based fluorescence in situ hy-
bridization for identification of bacteria in clinical
samples. Methods Mol Biol 2014;1211:261–271.
31. Bjarnsholt T, Alhede M, Alhede M, et al. The
in vivo biofilm. Trends Microbiol 2013;21:466–474.
32. Wong VW, Sorkin M, Glotzbach JP, Longaker MT,
Gurtner GC. Surgical approaches to create murine
models of human wound healing. J Biomed Bio-
tech 2011;2011:969618.
33. Gurjala AN, Geringer MR, Seth AK, et al. Devel-
opment of a novel, highly quantitative in vivo
model for the study of biofilm-impaired cutaneous
wound healing. Wound Repair Regen 2011;19:
400–410.
34. Ansell DM, Campbell L, Thomason HA, Brass A,
Hardman MJ. A statistical analysis of murine in-
cisional and excisional acute wound models.
Wound Repair Regen 2014;22:281–287.
35. Bundgaard L, Sorensen MA, Nilsson T, Salling E,
Jacobsen S. Evaluation of Systemic and Local
Inflammatory Parameters and Manifestations of
Pain in an Equine Experimental Wound Model. J
Equine Vet Sci 2018;68:81–87.
36. Celeste CJ, Deschene K, Riley CB, Theoret CL.
Regional differences in wound oxygenation during
normal healing in an equine model of cutaneous
fibroproliferative disorder. Wound Repair Regen
2011;19:89–97.
37. Gottrup F. Oxygen, wound healing and the de-
velopment of infection. Present status. Eur J Surg
2002;168:260–263.
38. Percival SL, McCarty S, Hunt JA, Woods EJ. The
effects of pH on wound healing, biofilms, and
antimicrobial efficacy. Wound Repair Regen 2014;
22:174–186.
39. Alhede M, Bjarnsholt T, Jensen PO, et al. Pseu-
domonas aeruginosa recognizes and responds
aggressively to the presence of polymorphonu-
clear leukocytes. Microbiol 2009;155:3500–3508.
40. Zhao G, Usui ML, Lippman SI, et al. Biofilms and
Inflammation in Chronic Wounds. Adv Wound
Care 2013;2:389–399.
41. Yang Q, Phillips PL, Sampson EM, et al. Devel-
opment of a novel ex vivo porcine skin explant
model for the assessment of mature bacterial
biofilms. Wound Repair Regen 2013;21:704–714.
42. Wolcott RD, Rumbaugh KP, James G, et al. Biofilm
maturity studies indicate sharp debridement
opens a timedependent therapeutic window. J
Wound Care 2010;19:320–328.
43. Fierheller M, Sibbald RG. A clinical investigation
into the relationship between increased peri-
wound skin temperature and local wound infec-
tion in patients with chronic leg ulcers. Adv Skin
Wound Care 2010;23:369–379.
44. Thomsen TR, Aasholm MS, Rudkjøbing VB, et al.
The bacteriology of chronic venous leg ulcer ex-
amined by culture-independent molecular meth-
ods. Wound Repair Regen 2010;18:38–49.
45. Hoiby N, Bjarnsholt T, Moser C, et al. ESCMID
guideline for the diagnosis and treatment of bio-
film infections 2014. Clin Microbiol Infect 2015;21:
S1–S25.
46. Burmølle M, Thomsen TR, Fazli M, et al. Biofilms
in chronic infections–a matter of opportunity–
monospecies biofilms in multispecies infections.
FEMS Immunol Med Microbiol 2010;59:324–336.
47. Rhoads DD, Wolcott RD, Sun Y, Dowd SE. Com-
parison of culture and molecular identification of
bacteria in chronic wounds. Int J Mol Sci 2012;13:
2535–2550.
48. Lipsky BA, Aragon-Sanchez J, Diggle M, et al.
IWGDF guidance on the diagnosis and manage-
ment of foot infections in persons with diabetes.
Diabetes Metab Res Rev 2016;32:45–74.
49. Gottrup F, Apelqvist J, Bjarnsholt T, et al. EWMA
document: antimicrobials and non-healing
wounds. Evidence, controversies and suggestions.
J Wound Care 2013;22:S1–S89.
50. Zhao G, Hochwalt PC, Usui ML, et al. Delayed
wound healing in diabetic (db/db) mice with
Pseudomonas aeruginosa biofilm challenge: a
model for the study of chronic wounds. Wound
Repair Regen 2010;18:467–477.
Abbreviations and Acronyms
AAEP ¼ American Association of Equine
Practitioners
BacUni ¼ universal bacterial
CFU ¼ colony-forming units
CLSM ¼ confocal laser scanning microscopy
DAPI ¼ 4¢,6¢-diamidino-2-phenylindole
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